close 73% van de retail rekeningen verliezen gelden met de handel in CFD`s bij deze aanbieder. Investeringen zijn risicovol en zijn niet geschikt voor alle beleggers. CFD`s zijn complexe instrumenten met een hoog risico om snel gelden te verliezen vanwege het hefboomeffect. 73% van de retail beleggers lijdt verlies bij het handelen in CFD`s met deze aanbieder. Het is belangrijk dat u goed begrijpt hoe CFD`s werken en dat u nagaat of u zich het hoge risico op verlies kunt permitteren.
ZoekenZoeken
Change languageNederlands
Dashboard

MDT

100.7

-0.04%↓

A

135.8

-0.01%↓

VEEV

217.48

-2.72%↓

HQY

83.14

-2.48%↓

NEOG

10.28

+2.8%↑

MDT

100.7

-0.04%↓

A

135.8

-0.01%↓

VEEV

217.48

-2.72%↓

HQY

83.14

-2.48%↓

NEOG

10.28

+2.8%↑

MDT

100.7

-0.04%↓

A

135.8

-0.01%↓

VEEV

217.48

-2.72%↓

HQY

83.14

-2.48%↓

NEOG

10.28

+2.8%↑

MDT

100.7

-0.04%↓

A

135.8

-0.01%↓

VEEV

217.48

-2.72%↓

HQY

83.14

-2.48%↓

NEOG

10.28

+2.8%↑

MDT

100.7

-0.04%↓

A

135.8

-0.01%↓

VEEV

217.48

-2.72%↓

HQY

83.14

-2.48%↓

NEOG

10.28

+2.8%↑

Home・Aandelen Lijst・VIRIDIAN THERAPEUTICS INC
Search

VIRIDIAN THERAPEUTICS INC

Open

SectorGezondheidszorg

33.41 1.55

Strong Buy

Prijsupdate 27 jan 2026, 20:59 UTC

BuySell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

32.43

Max

33.54

Belangrijke statistieken

By Trading Economics

Inkomsten

66M

-35M

Verkoop

70M

71M

Winstmarge

-49.028

Werknemers

143

EBITDA

66M

-34M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+35.14% upside

Dividenden

By Dow Jones

Volgende Winsten

25 feb 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

1B

3.2B

Vorige openingsprijs

31.86

Vorige sluitingsprijs

33.41

Nieuwssentiment

By Acuity

33%

67%

83 / 352 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

12 / 13.14 Steun & Weerstand

VIRIDIAN THERAPEUTICS INC Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

26 jan 2026, 23:49 UTC

Populaire aandelen

Stocks to Watch: Agilysys, Nucor, Humana, UnitedHealth

DJ

Lezen

26 jan 2026, 23:09 UTC

Belangrijke Marktbewegers

Health Insurers' Shares Fall After Government Proposes Flat Medicare Advantage Rate

DJ

Lezen

26 jan 2026, 23:52 UTC

Marktinformatie

Gold's Path of Least Resistance Still Looks Higher, Technical Analysis Shows -- Market Talk

DJ

Lezen

26 jan 2026, 23:46 UTC

Marktinformatie

Nikkei May Decline as Yen's Rebound Raises Caution Over Earnings -- Market Talk

DJ

Lezen

26 jan 2026, 23:37 UTC

Marktinformatie

Gold Rises Amid Concerns Over Tariffs -- Market Talk

DJ

Lezen

26 jan 2026, 22:41 UTC

Marktinformatie

Australian 4Q CPI To Provide Smoking Gun For Hike -- Market Talk

DJ

Lezen

26 jan 2026, 22:26 UTC

Winsten

Karoon Expects Capex of US$110 Million-US$135 Million in 2026

DJ

Lezen

26 jan 2026, 22:26 UTC

Winsten

Karoon Expects Operating Costs to Fall Once Transition of Bauna FPSO Operatorship Completes

DJ

Lezen

26 jan 2026, 22:25 UTC

Winsten

Karoon Energy Expects Unit Production Cost of US$12-US$15/BOE in 2026

DJ

Lezen

26 jan 2026, 22:25 UTC

Winsten

Karoon Energy Expects Output to Rise in 2H Following Bauna Investment Program

DJ

Lezen

26 jan 2026, 22:25 UTC

Winsten

Karoon Energy Expects Output of 8.1 Million-9.2 Million BOE in 2026

DJ

Lezen

26 jan 2026, 22:24 UTC

Winsten

Karoon Energy 4Q Sales Revenue US$156.1 Million

DJ

Lezen

26 jan 2026, 22:23 UTC

Winsten

Karoon Energy 4Q Sales Volumes 2.65 Million BOE, Up 5% on Quarter

DJ

Lezen

26 jan 2026, 22:23 UTC

Winsten

Karoon Energy: Bauna FPSO Efficiency Increased to 98.8%

DJ

Lezen

26 jan 2026, 22:23 UTC

Winsten

Karoon Energy FY Oil, Natural Gas Production 10.3 Million BOE

DJ

Lezen

26 jan 2026, 22:22 UTC

Winsten

Karoon Energy 4Q Oil, Natural Gas Production 2.37 Million BOE

DJ

Lezen

26 jan 2026, 22:05 UTC

Acquisities, Fusies, Overnames

Fortescue: Alta Copper Shareholders Approve Takeover

DJ

Lezen

26 jan 2026, 22:02 UTC

Acquisities, Fusies, Overnames

Senate Antitrust Panel Chair Raises Concerns Over Netflix-Warner Deal -- WSJ

DJ

Lezen

26 jan 2026, 21:50 UTC

Marktinformatie
Winsten

Financial Services Roundup: Market Talk

DJ

Lezen

26 jan 2026, 21:50 UTC

Marktinformatie

Auto & Transport Roundup: Market Talk

DJ

Lezen

26 jan 2026, 21:34 UTC

Winsten

Nucor: Steel Products Segment Expected Improved Earnings in 1Q Due to Increased Volumes on Stable Pricing >NUE

DJ

Lezen

26 jan 2026, 21:34 UTC

Winsten

Nucor: Steel Mills Segment Expected Increase Is Due to Higher Volumes and Higher Realized Prices Across All Major Pdt Categories >NUE

DJ

Lezen

26 jan 2026, 21:34 UTC

Winsten

Nucor: Raw Materials Segment Is Expected to Have Increased Earnings in 1Q >NUE

DJ

Lezen

26 jan 2026, 21:34 UTC

Winsten

Nucor: 1Q Earnings Expected to Increase Across All Three Operating Segments, With the Largest Increase in Steel Mills Segment >NUE

DJ

Lezen

26 jan 2026, 21:30 UTC

Acquisities, Fusies, Overnames

Eaton Stock Rises on Spin-Off Plan. Why It's Going All-In on Planes and AI Data Centers. -- Barrons.com

DJ

Lezen

26 jan 2026, 21:30 UTC

Winsten

Nucor 4Q Sales $7.69B >NUE

DJ

Lezen

26 jan 2026, 21:30 UTC

Winsten

Nucor 4Q Net $378M >NUE

DJ

Lezen

26 jan 2026, 21:30 UTC

Winsten

Nucor 4Q Steel Mills Total Shipments 5.91M Tons >NUE

DJ

Lezen

26 jan 2026, 21:30 UTC

Winsten

Nucor 4Q Total Tons Shipped to Outside Customers Down 9% >NUE

DJ

Lezen

26 jan 2026, 21:30 UTC

Winsten

Nucor 4Q EPS $1.64 >NUE

DJ

Lezen

Peer Vergelijking

Prijswijziging

VIRIDIAN THERAPEUTICS INC Prognose

Koersdoel

By TipRanks

35.14% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 44.5 USD  35.14%

Hoogste 61 USD

Laagste 34 USD

Gebaseerd op 13 Wall Street-analisten die 12-maands prijsdoelen bieden voor VIRIDIAN THERAPEUTICS INC - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

13 ratings

13

Buy

0

Hold

0

Sell

Gebaseerd op 13 analisten die aandelenratings hebben gegeven aan VIRIDIAN THERAPEUTICS INC - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

12 / 13.14Steun & Weerstand

Korte Termijn

Very Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Gemiddeld Termijn

Bearish Evidence

All events are bearish.

Lange Termijn

Strong Bearish Evidence

All events are bearish.

Sentiment

By Acuity

83 / 352 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Andere aandelen uit de sector

MDT

Medtronic PLC

100.7

↓-0.04%

A

Agilent Technologies Inc

135.8

↓-0.01%

VEEV

Veeva Systems Inc

217.48

↓-2.72%

HQY

HealthEquity Inc

83.14

↓-2.48%

NEOG

Neogen Corp

10.28

↑ +2.8%
help-icon Live chat